A new mode of inhibition.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39158026.
- Also identified by DOI 10.7554/eLife.101446 and PMC identifier 11333039.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Complementary structural biology approaches reveal how an agonist and a covalent inhibitor simultaneously bind to a nuclear receptor.
Medical subject headings
- Receptors, Cytoplasmic and Nuclear